framycetin has been researched along with Cardiac Hypertrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartman, TJ; Martin, JL; Russell, B; Samarel, AM; Solaro, RJ | 1 |
1 other study(ies) available for framycetin and Cardiac Hypertrophy
Article | Year |
---|---|
CapZ dynamics are altered by endothelin-1 and phenylephrine via PIP2- and PKC-dependent mechanisms.
Topics: Actin Cytoskeleton; Animals; Benzophenanthridines; CapZ Actin Capping Protein; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Endothelin-1; Fluorescence Recovery After Photobleaching; Green Fluorescent Proteins; Myocytes, Cardiac; Neomycin; Phenylephrine; Phosphatidylinositol 4,5-Diphosphate; Protein Binding; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sarcomeres | 2009 |